Shanghai, China——Recently, Jiaxing TechnoDerma Medicines Inc., a biotech start-up invested and incubated by Viva BioInnovator, which focused on the R&D of innovative drugs for skin indications, announced the completion of tens of millions of yuan in Series A financing. The financing funds will be used to advance the clinical trials and follow-up R&D, and strengthen the development of the R&D team.
TechnoDerma Medicines announced the completion of Series A Financing
April 14, 2021
Next article :
Previous article :